Belmont Global Advisors’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$12.7M Sell
459,095
-20,180
-4% -$534K 12.06% 2
2016
Q2
$11.7M Buy
479,275
+252,250
+111% +$7.16M 11.22% 3
2016
Q1
$7.63M Buy
227,025
+166,485
+275% +$5.24M 7.76% 4
2015
Q4
$1.81M Buy
+60,540
New +$2.04M 2.34% 8

Other funds holding PGEN

Belmont Global Advisors's PGEN Position: Q3 2016 in Review

Belmont Global Advisors increased its Precigen (PGEN) stake by 7.1% in Q3 2016, buying an estimated $534K and bringing the position to 303,255 shares worth $8.42M. The position accounts for 7.97% of the portfolio, ranked #5.

Belmont Global Advisors first reported a position in PGEN in Q4 2013 and has held it in 12 quarters since. The position peaked at $12.9M in Q1 2016. 168 funds tracked by Wall St. Rank hold PGEN as of Q3 2016.

  • Belmont Global Advisors held 303,255 shares of Precigen worth $8.42M as of Q3 2016.
  • Belmont Global Advisors bought 20,180 Precigen shares in Q3 2016, an estimated $534K.
  • Precigen made up 7.97% of Belmont Global Advisors's portfolio in Q3 2016, its #5 holding.
  • Belmont Global Advisors first reported a position in Precigen in Q4 2013 and has held it in 12 quarters since.
  • Belmont Global Advisors's Precigen position peaked at $12.9M in Q1 2016.
  • 168 funds tracked by Wall St. Rank held Precigen as of Q3 2016.

Based on Belmont Global Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.